Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Sales | 623 | -4 | 11 | -95 | 246 |
| Cost of Goods | 348 | N/A | N/A | N/A | N/A |
| Gross Profit | 275 | -4 | 11 | -95 | 246 |
| Operating Expenses | 18,014 | 7,469 | 4,485 | 3,582 | 4,769 |
| Operating Income | -17,392 | -7,473 | -4,474 | -3,677 | -4,523 |
| Other Income | 238 | 328 | 313 | 311 | 348 |
| Pre-tax Income | -17,154 | -7,145 | -4,160 | -3,367 | -4,175 |
| Net Income Continuous | -12,272 | -6,174 | -3,707 | -4,778 | -4,111 |
| Net Income Discontinuous | -205 | N/A | N/A | N/A | N/A |
| Net Income | $-12,478 | $-6,174 | $-3,707 | $-6,554 | $-4,111 |
| EPS Basic Total Ops | -3.50 | -1.80 | -1.10 | -2.10 | -1.20 |
| EPS Basic Continuous Ops | -3.40 | -1.80 | -1.08 | -1.45 | -1.22 |
| EPS Basic Discontinuous Ops | -0.10 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -3.50 | -1.80 | -1.10 | -2.10 | -1.20 |
| EPS Diluted Continuous Ops | -3.40 | -1.80 | -1.08 | -1.45 | -1.22 |
| EPS Diluted Discontinuous Ops | -0.10 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-17,139 | $-7,238 | $-4,243 | $-3,425 | $-4,294 |